Genfit gets positive results in pre-clinical study of GFT505 with statins
Friday, January 15, 2010 15:00 IST Lille, Cambridge
Genfit, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases
